Table 2. Differentially expressed vitreal miRNAs.
DE miRNAs | ERM + MH vs Cs | MH vs Cs | ERM vs Cs | ERM vs MH | ||||
---|---|---|---|---|---|---|---|---|
FC | t-test | FC | t-test | FC | t-test | FC | t-test | |
miR-19b | -9.13 | 0.00004 | -14.1 | 0.002 | -6.29 | 0.0004 | 2.24 | 0.046 |
miR-24 | -7.52 | 0.004 | -11.58 | 0.012 | -6.38 | 0.016 | - | NS |
miR-29a | - | NS | - | NS | - | NS | -1.94 | 0.031 |
miR-30a-3p | - | NS | - | NS | - | NS | 11.08 | 0.026 |
miR-142-3p | 5.32 | 0.011 | 5.81 | 0.048 | 4.83 | 0.021 | 3.31 | 0.013 |
miR-155 | 6.88 | 0.018 | 7.21 | 0.015 | 6.45 | 0.019 | - | NS |
miR-451 | 6.52 | 0.041 | 5.35 | 0.045 | 6.96 | 0.038 | - | NS |
miR-574-3p | - | NS | -7.55 | 0.018 | - | NS | 7.48 | 0.047 |
miR-1290 | -6.29 | 0.036 | -8.14 | 0.031 | -5.74 | 0.042 | - | NS |
Differentially Expressed vitreal miRNAs by single TaqMan® assays in the vitreous humor of patients affected by macular hole and epiretinal membrane with respect to controls and comparison between pathological classes.
t test: significant p-value < 0.05.
FC, Fold Change; Cs, Controls; NS, Not Significant.